Christopher J Coughlin bought $594K of Centene (CNC)
Executed Dec 16 2024, disclosed Dec 17 2024, 1 day later.
Over the 21 trading sessions from the disclosed entry session (Dec 17 2024), the stock returned +5.8% (delay-adjusted); from the execution session (Dec 16 2024), +6.5%. Derived: entry at the session's open, exit at the close 20 sessions later.
Christopher J Coughlin (Director) filed 1 Form 4 report in the past 24 months (1 purchase, 0 sales), most often in Centene Corporation (CNC). Across 1 priced purchase filing, the average 21-session return was +6.5% from execution and +5.8% from disclosure (delay-adjusted; derived). The largest single filing was $594K of CNC (10,000 sh × $59.44, as filed), executed Dec 16 2024.
Healthcare · Centene Corporation operates as a managed care company that provides programs and services to under-insured families, and commercial organi…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→